The impact of treatment choices on potential drug–drug interactions in hypertensive patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The impact of treatment choices on potential drug–drug interactions in hypertensive patients

Published:2021-12-18 Issue: Volume: Page:
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Perić Aneta¹²^ORCID,Udilović Ana³^ORCID,Dobrić Silva²^ORCID,Vezmar Kovačević Sandra⁴^ORCID

Affiliation:

1. Sector for Pharmacy Military Medical Academy Belgrade Serbia

2. Faculty of Medicine of the Military Medical Academy University of Defence Belgrade Serbia

3. Deutsche Rentenversicherung Bayern Süd Rehafachzentrum Bad Füssing‐Passau Standort Passau Pasau Germany

4. Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy University of Belgrade Belgrade Serbia

Funder

Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15168

Reference38 articles.

1. Epidemiology of hypertension in Serbia: results of a national survey;Grujić V;J Epidemiol,2012

2. Long‐term and recent trends in hypertension awareness, treatment, and control in 12 high‐income countries: an analysis of 123 nationally representative surveys;NCD Risk Factor Collaboration (NCD‐RisC);Lancet,2019

3. Hypertension and Drug Adherence in the Elderly

4. Potential drug–drug interactions among medications prescribed to hypertensive patients;Kothari N;J Clin Diagn Res,2014

5. 2020 International Society of Hypertension Global Hypertension Practice Guidelines

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Significance and Patterns of Potential Drug–Drug Interactions in Cardiovascular Patients: Focus on Low-Dose Aspirin and Angiotensin-Converting Enzyme Inhibitors;Journal of Clinical Medicine;2024-07-23

2. Potential drug–drug interactions analysis in Polish pediatric pneumonology units, including cystic fibrosis patients;The Journal of Clinical Pharmacology;2024-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3